ProCE Banner Activity

An Expert Perspective on Antibody–Drug Conjugates in Non-Small-Cell Lung Cancer

Conference Coverage
Clinical Thought
In this commentary, D. Ross Camidge, MD, PhD, provides his thoughts on the latest advances and potential of ADCs in the treatment of non-small-cell lung cancer.

Released: January 26, 2021

Expiration: January 25, 2022

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.